Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

795
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
795
Cancer Survival Analysis01:21

Cancer Survival Analysis

590
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
590
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

336
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
336
Decision Making: P-value Method01:09

Decision Making: P-value Method

6.7K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.7K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

271
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
271
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.3K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-related quality of life among multimorbid patients using the EQ-5D-5L value set for India.

Frontiers in public health·2025
Same author

Cost-effectiveness of portable-automated ABR for universal neonatal hearing screening in India.

Frontiers in public health·2024
Same author

Cost-effectiveness of population-based screening for microalbuminuria in people with type 2 diabetes mellitus in India.

International journal of technology assessment in health care·2023
Same author

DMEK surgical training: An instructional guide on various wet-lab methods.

Survey of ophthalmology·2023
Same author

Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India.

The Lancet regional health. Southeast Asia·2023
Same author

Cost-effectiveness of Post-Mastectomy Radiotherapy (PMRT) for breast cancer in India: An economic modelling study.

The Lancet regional health. Southeast Asia·2023
Same journal

Corrigendum to "Nuances in ATP7B Genetic Testing and Interpretation in India" [J Clin Exp Hepatol 16 (1) (2026) 103205].

Journal of clinical and experimental hepatology·2026
Same journal

Hepatic Melioidosis: A State-of-the-Art Review.

Journal of clinical and experimental hepatology·2026
Same journal

Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases.

Journal of clinical and experimental hepatology·2026
Same journal

Redefinition of Fatty Liver Disease: Stigma or Fatphobia?

Journal of clinical and experimental hepatology·2026
Same journal

Relative Adrenal Insufficiency in Decompensated Cirrhosis With Hyponatremia: Disease Severity Marker or Therapeutic Target?

Journal of clinical and experimental hepatology·2026
Same journal

Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score Analysis.

Journal of clinical and experimental hepatology·2026
See all related articles

Related Experiment Video

Updated: Dec 26, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.3K

Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians.

Nidhi Gupta1, Rohan Verma2, Radha K Dhiman3

  • 1Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India.

Journal of Clinical and Experimental Hepatology
|March 20, 2020
PubMed
Summary
This summary is machine-generated.

Cost-effectiveness analysis (CEA) informs healthcare funding decisions by comparing intervention costs to health gains. Decision models, alongside or instead of randomized controlled trials (RCTs), provide more comprehensive data for robust CEA.

Keywords:
BCLC, Barcelona Clinic Liver CancerBSC, Best Supportive CareCAD, Coronary Artery DiseaseCEA, Cost-Effectiveness AnalysisDALY, Disability Adjusted Life YearEE, Economic EvaluationHCC, Hepatocellular CarcinomaHCV, Hepatitis C VirusHPV, Human PapillomavirusHib, Hemophilus InfluenzaICER, Incremental Cost-Effectiveness RatioPD, Progressive DiseasePFS, Progression-Free StateQALY, Quality Adjusted Life YearRCT, Randomized controlled trialSNCU, Special Newborn Care Unitcost-effectivenessdecision modeldecision treeeconomic evaluationmarkov model

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

745

Related Experiment Videos

Last Updated: Dec 26, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

745

Area of Science:

  • Health Economics
  • Clinical Decision Making
  • Public Health Policy

Background:

  • Cost-effectiveness analysis (CEA) is vital for healthcare intervention funding and treatment protocol decisions, especially in resource-limited settings.
  • Randomized controlled trials (RCTs) are valuable for efficacy but offer incomplete data for comprehensive CEA.
  • Decision models are essential for a complete economic evaluation of healthcare interventions.

Purpose of the Study:

  • To demonstrate the application of decision model-based economic evaluation for CEA.
  • To highlight the advantages of decision models over RCTs for generating comprehensive cost and consequence data.
  • To emphasize the utility of decision models for policy-relevant health economic evidence.

Main Methods:

  • Application of decision model-based economic evaluation using decision trees and Markov models.
  • Utilizing utility-based measures like Quality-Adjusted Life Years (QALYs) or Disability-Adjusted Life Years (DALYs).
  • Incorporating evidence from multiple sources beyond single RCTs.

Main Results:

  • Decision models enable computation of utility-based health benefits (e.g., QALYs/DALYs).
  • They allow measurement of distal costs and consequences, offering a broader perspective.
  • Decision models facilitate comparisons between multiple interventions and evidence sources, enhancing generalizability.

Conclusions:

  • Decision models are crucial for comprehensive CEA, providing more robust evidence than RCTs alone.
  • Their application supports better clinical use and policy relevance in healthcare decision-making.
  • Decision models enhance the acceptability and applicability of health economic evidence for policymakers.